Cargando…
Warfarin: The End or the End of One Size Fits All Therapy?
Oral anticoagulants are required for both treatment and prophylaxis in many different diseases. Clinicians and patients now have a choice of oral anticoagulants, including the vitamin K antagonists (of which warfarin is the most widely used and is used as the exemplar in this paper), and direct oral...
Autor principal: | Pirmohamed, Munir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163581/ https://www.ncbi.nlm.nih.gov/pubmed/29958440 http://dx.doi.org/10.3390/jpm8030022 |
Ejemplares similares
-
The End of “One Size Fits All” Sepsis Therapies: Toward an Individualized Approach
por: Vincent, Jean-Louis, et al.
Publicado: (2022) -
Patient education and care for end-stage kidney disease: one size never fits all
por: Oh, Kook-Hwan
Publicado: (2020) -
Ethnic Diversity and Warfarin Pharmacogenomics
por: Asiimwe, Innocent G., et al.
Publicado: (2022) -
One size does not fit all
por: Tautz, Diethard
Publicado: (2014) -
One Size Does Not Fit All: Heterogeneity in Developmental Hematopoiesis
por: Barone, Cristiana, et al.
Publicado: (2022)